Peptide Sciences Is Gone, Patients Are Panicking Over Where to Turn Next, and California Trim Clinic Says the Internet Peptide Free-for-All Just Hit Its Loudest Wake-Up Call Yet

|

Peptide Sciences is gone, FDA warning letters are hitting sellers using “research purposes only” language, and a July FDA advisory meeting is now set to review whether several widely discussed peptides may qualify for 503A compounding-list consideration. The original release framed Peptide Sciences’ shutdown as a turning point for patients who had relied on gray-market peptide vendors for compounds such as Semaglutide, Tirzepatide, and BPC-157. California Trim Clinic says the peptide market is not losing demand. It is losing its illusion of stability, as patients watch vendor shutdowns, FDA scrutiny, and possible regulated access pathways collide at the same time. The clinic says this is the moment patients need licensed evaluation, pharmacy standards, and physician-guided care, not panic-buying, self-mixing, or anonymous vendor hopping.

Deutsche Dental Technologien to Exhibit at Pikos Institute 2026 Full Arch Complications: A 360° Global Summit

|

Deutsche Dental Technologien (DeutscheDT.com), the leading U.S. distributor of authentic German-made dental instruments from Helmut Zepf Medizintechnik and Busch & Co., will exhibit at the highly anticipated Pikos Institute Full Arch Complications: A 360° Global Summit. This landmark 2-day event, held at the luxurious JW Marriott Grande Lakes in Orlando, focuses exclusively on real-world complications in full arch immediate… Read more »